icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
LdQeKGcmXSL8UV6d